Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Rnaissance AG LLC has 1 pending office action in the Biotechnology & Pharmaceuticals technology area. The company's active prosecution is concentrated under 1 distinct examiner and 1 distinct art unit. This reflects a focused approach to its current filings, where the company is likely seeking protection for a specific biotechnology innovation. The lack of multiple pending actions or art units suggests a streamlined portfolio management strategy at this stage. This concentration allows for a dedicated legal focus on a single examination process.
RYAN, DOUGLAS CHARLES is the busiest examiner, with 1 busiest examiner pending action. This single action represents the total pending workload for the company. The examiner's specific review within the 1 art unit will determine the immediate success of the company's biotechnology patent strategy. Practitioners must carefully address the requirements of this 1 examiner to advance the 1 pending action. The company's current intellectual property trajectory is entirely shaped by the outcome of this single examination process. Success in the Biotechnology & Pharmaceuticals area depends on this individual review.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Double-patenting + other | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| RYAN, DOUGLAS CHARLES | 1 | 39.2% | +47.6% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17615513 | IMPROVED METHODS AND COMPOSITIONS FOR INCREASED DOUBLE STRANDED RNA PRODUCTION | RYAN, DOUGLAS CHARLES | 29d overdue |
| Art Unit | Apps |
|---|---|
| 1635 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 17615513 | IMPROVED METHODS AND COMPOSITIONS FOR INCREASED DOUBLE STRANDED RNA PRODUCTION | RYAN, DOUGLAS CHARLES | 1635 | §103§112DP | Final Rejection | 29d overdue | Pending | Nov 30, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial